Strong Quarterly Results Lifted Merit Medical Systems (MMSI) in Q1
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Merit Medical Systems Inc (MMSI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Impax Asset Management Ian Simm | 100,000 | $10,571,000 | -17% | 0.06% |
| 2. | Bailard Inc Thomas Bailard | 24,350 | $2,574,039 | 0.07% | |
| 3. | Bayforest Capital Theodoros Tsagaris | 385 | $24,419 | 0.02% | |
| 4. | Altium Capital Jacob Gottlieb | 0 | $0 | 0% | |
| 5. | Leucadia National Ian Cumming And Joseph Steinberg | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $43.11 | 1,159 | 1,584 | 2020-08-04 | Filing | ||
| $25.50 | 2,525 | Officer | 2,988 | 2019-11-05 | Filing | |
| $40.00 | 5,000 | Officer | 5,000 | 2019-07-30 | Filing | |
| $9.63 | 2,000 | Director | 2,000 | 2013-05-01 | Filing | |
| $9.82 | 90 | Officer, Director | 90 | 2013-04-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $104.53 | 5,000 | 28,369 | 2025-04-01 | Filing | ||
| $103.75 | 2,590 | 7,734 | 2025-03-05 | Filing | ||
| $103.75 | 410 | 10,324 | 2025-03-05 | Filing | ||
| $103.75 | 20,000 | 1,086,028 | 2025-03-05 | Filing | ||
| $104.05 | 11,320 | 1,106,028 | 2025-03-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,175,660 | $969,959,001 | 0.02% | |
| 2. | 2,265,173 | $239,451,438 | 3.61% | |
| 3. | 628,126 | $66,399,199 | 0.5% | |
| 4. | 425,823 | $45,013,761 | 0.01% | |
| 5. | 319,960 | $33,822,972 | 0.02% |
News See All
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q1 2025 Earnings Call Transcript
Operator: Welcome to the Merit Medical Systems First Quarter 2025 Earnings Conference Call. At this time, all participants have been placed in a listen-only mode.
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q4 2024 Earnings Call Transcript
Operator: Please stand by and welcome to the Merit Medical Systems Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are placed in listen-only mode.
Should You Invest in Merit Medical Systems (MMSI)?
Riverwater Partners, an investment management company, released its “Small Cap Core Strategy” Q3 2024 investor letter. A copy of the letter can be downloaded here.
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q3 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Merit Medical Q3 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Merit Medical Systems (MMSI) Exceeded Earnings And Sales Growth
Conestoga Capital Advisors, an asset management company, released its “Small Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Merit Medical Systems Second Quarter 2024 Earnings Conference Call.
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the MMSI First Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q4 2023 Earnings Call Transcript
Merit Medical Systems, Inc. beats earnings expectations. Reported EPS is $0.81, expectations were $0.77. Merit Medical Systems, Inc.
Here’s Why Merit Medical Systems (MMSI) Fell in Q3
Chartwell Investment Partners, LLC, an affiliate of Carillon Tower Advisers, Inc., released the “Carillon Chartwell Small Cap Value Fund” third quarter 2023 investor letter.